Elrashied A. E. Garelnabi

Author

University of Khartoum

Also Known As

E.A.E. Garelnabi, Elrashied A. E. Garelnabi, Elrashied A. Garelnabi, Elrashied A.E. Garelnabi

Publications

180

Citations

H-Index

Concepts

All Affiliations

University of Khartoum University of Bradford University of Gezira Prince Sattam Bin Abdulaziz University Mansoura University

About

Elrashied A. E. Garelnabi is an author at University of Khartoum specializing in medicine, pharmacology, and medicinal chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	128
2	Natural Sciences	3	3	53
3	Biochemistry	3	3	53
4	Allergy	1	1	75
5	Chemical Biology	1	1	20

Elrashied A. E. Garelnabi

Publications

154

Citations

H-Index

Page 1

	Year	Citations
Secondary metabolites as anti-inflammatory agents Mona S. Mohammed, Wadah Osman, Elrashied A. E. Garelnabi, The Journal of Phytopharmacology InflammationRheumatologyAnti Inflammatory DrugsBacterial InfectionsAnti-inflammatory	2014	75
Identification of some chalcone analogues as potential antileishmanial agents: An integrated in vitro and in silico evaluation Marwa Osman, Talal Ahmed Awad, Shaza W. Shantier, Arabian Journal of Chemistry Bioorganic ChemistryAntiparasitic AgentPharmacotherapyAntimicrobial ChemotherapyChalcone 4	2022	22
Synthesis and Quantitative Structure–Activity Relationship of Imidazotetrazine Prodrugs with Activity Independent of <i>O</i>6-Methylguanine-DNA-methyltransferase, DNA Mismatch Repair, and p53 Dimitrios Pletsas, Elrashied A. E. Garelnabi, Li Li, Journal of Medicinal Chemistry Pharmaceutical ScienceActivity IndependentChemical BiologyQuantitative Structure–activity RelationshipPharmaceutical Chemistry	2013	20
Design of Novel Letrozole Analogues Targeting Aromatase for Breast Cancer: Molecular Docking, Molecular Dynamics, and Theoretical Studies on Gold Nanoparticles Alaa Edris, Mohammed Abdelrahman, Wadah Osman, Metabolites	2023	14
Computational Insights into Natural Antischistosomal Metabolites as SmHDAC8 Inhibitors: Molecular Docking, ADMET Profiling, and Molecular Dynamics Simulation Abdulrahim A. Alzain, Rua M. Mukhtar, Nihal Abdelmoniem, Metabolites	2023	12
Strategy for Imidazotetrazine Prodrugs with Anticancer Activity Independent of MGMT and MMR Elrashied A. E. Garelnabi, Dimitrios Pletsas, Li Li, ACS Medicinal Chemistry Letters New CompoundsOrganic ChemistryPharmacotherapyImidazotetrazine RingHeterocycle Chemistry	2012	11

Page 1